Clinical trial
A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of…
NCT00087997 · Synta Pharmaceuticals Corp., Industry · Completed
Key facts
| NCT number | NCT00087997 |
|---|---|
| Title | A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas |
| Lead sponsor | Synta Pharmaceuticals Corp., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Soft Tissue Sarcoma |
| Intervention type | Drug |
| Interventions | STA-4783 |
| Enrollment | 80 |
| Start date | Jul 1, 2004 |
| Completion | Oct 1, 2005 |
| First posted | Jul 23, 2004 |
| Last update posted | Jun 20, 2006 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: